Keywords: sanofi, extends, term, immunogen, cancer, accord, usa

Sanofi extends term of ImmunoGen cancer R&D accord

Article | 25 September 2006

Print This

The USA's ImmunoGen says that the local unit of leading French drugmaker Sanofi-Aventis has exercised its right to extend the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in